Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.61 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 4/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.51 |
| ▸ | AGXT | P21549 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16603392 | 1.00 | MAOB (0.62) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL12918621 | 1.00 | MAOB (0.62) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL18635916 | 1.00 | MAOB (0.62) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL8929713 | 0.93 | MAOB (0.69) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL891195 | 0.93 | MAOB (0.69) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL762195 | 0.93 | MAOB (0.69) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL8930213 | 0.93 | MAOB (0.69) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL12885558 | 0.92 | MAOB (0.56) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL14864480 | 0.92 | GSTP1 (0.63) | MAOBNPC1RAB9APARP10CASP3 | |
| SCHEMBL260484 | 0.91 | MAOB (0.58) | MAOBNPC1RAB9APARP10CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2441745-B1 | Biphenyl benzyl ether marker compounds for liquid hydrocarbons and other fuels and oils | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-08-26 | — | — | EP | claimed |
| US-9005314-B2 | Biphenyl benzyl ether marker compounds for liquid hydrocarbons and other fuels and oils | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-14 | — | — | US | claimed |
| EP-2441745-B1 | Biphenyl benzyl ether marker compounds for liquid hydrocarbons and other fuels and oils | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-9005314-B2 | Biphenyl benzyl ether marker compounds for liquid hydrocarbons and other fuels and oils | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-14 | — | — | US | disclosed |
| US-20120090225-A1 | BIPHENYL BENZYL ETHER MARKER COMPOUNDS FOR LIQUID HYDROCARBONS AND OTHER FUELS AND OILS | DOW GLOBAL TECHNOLOGIES LLC | 2012-04-19 | — | — | US | disclosed |
| EP-2441745-A1 | Biphenyl benzyl ether marker compounds for liquid hydrocarbons and other fuels and oils | ANGUS Chemical Company (US) | 2012-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120090225-A1 | BIPHENYL BENZYL ETHER MARKER COMPOUNDS FOR LIQUID HYDROCARBONS AND OTHER FUELS AND OILS | CYP1A1, FABP4, CYP2E1 | MAOB 943/4885NPC1 587/4885RAB9A 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.